Latest News
Genentech's Risdiplam Meets Primary Endpoint in Pivotal FIREFISH Trial in Infants with Type 1 Spinal Muscular Atrophy
24 January 2020 - - US-based biotechnology company Genentech has received positive topline results from the pivotal Part 2 of the FIREFISH study, evaluating risdiplam in infants aged 1-7 months with Type 1 spinal muscular atrophy, the company said.
Ferring's Propess Approved in Japan for Treatment for Cervical Ripening
24 January 2020 - - Swiss pharmaceutical company Ferring Pharmaceuticals' Propess (dinoprostone) has been approved by the Minister of Health, Labour and Welfare in Japan for initiation of cervical ripening in patients at term (from 37 compl...
Co-Diagnostics Designs Test for New Coronavirus Using CoPrimer Platform
24 January 2020 - - US-based molecular diagnostics company Co-Diagnostics, Inc. (NASDAQ: CODX) has completed principle design work for a PCR screening test for new coronavirus, 2019-nCoV, intended to address potential need for detection of the v...
Poxel Names Moller as Chief Scientific Officer
24 January 2020 - - French biopharmaceutical company POXEL SA has appointed David E. Moller, MD, as chief scientific officer, the company said.

Moller will be responsible for leading scientific-related activities to support the adva...
Pfizer's Greenstone and Digital Men's Health Clinic Roman Collaborate to Offer Patients Remote Access to the Only FDA-Approved Authorized Generic Version of Viagra 
24 January 2020 - - US-based Greenstone, Upjohn's US-based generics business and a wholly owned subsidiary of Pfizer Inc., and Roman, a digital healthcare clinic for men, have inked a supply agreement to offer Roman members access to the only FD...